BNP Paribas Financial Markets’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-572,196
| Closed | -$56.8M | – | 4607 |
|
|
2019
Q3 | $56.8M | Sell |
572,196
-490,944
| -46% | -$46.6M | 0.1% | 204 |
|
|
2019
Q2 | $98.3M | Sell |
1,063,140
-96,079
| -8% | -$9.12M | 0.2% | 116 |
|
|
2019
Q1 | $109M | Sell |
1,159,219
-1,695,691
| -59% | -$148M | 0.24% | 83 |
|
|
2018
Q4 | $183M | Buy |
2,854,910
+2,043,902
| +252% | +$151M | 0.43% | 34 |
|
|
2018
Q3 | $72.6M | Sell |
811,008
-421,348
| -34% | -$37.2M | 0.11% | 191 |
|
|
2018
Q2 | $97.9M | Buy |
1,232,356
+367,015
| +42% | +$30.5M | 0.16% | 125 |
|
|
2018
Q1 | $77.2M | Buy |
865,341
+322,010
| +59% | +$30.9M | 0.14% | 132 |
|
|
2017
Q4 | $56.7M | Sell |
543,331
-784,326
| -59% | -$88.5M | 0.1% | 193 |
|
|
2017
Q3 | $194M | Sell |
1,327,657
-44,380
| -3% | -$6.05M | 0.47% | 38 |
|
|
2017
Q2 | $178M | Buy |
1,372,037
+140,717
| +11% | +$17.2M | 0.54% | 29 |
|
|
2017
Q1 | $153M | Buy |
1,231,320
+923,919
| +301% | +$111M | 0.4% | 50 |
|
|
2016
Q4 | $35.6M | Sell |
307,401
-180,671
| -37% | -$20.1M | 0.17% | 108 |
|
|
2016
Q3 | $51M | Buy |
488,072
+192,259
| +65% | +$20.8M | 0.21% | 89 |
|
|
2016
Q2 | $29.2M | Sell |
295,813
-102,682
| -26% | -$10.6M | 0.13% | 111 |
|
|
2016
Q1 | $39.9M | Buy |
398,495
+13,309
| +3% | +$1.37M | 0.17% | 101 |
|
|
2015
Q4 | $46.1M | Buy |
385,186
+207,178
| +116% | +$24M | 0.11% | 151 |
|
|
2015
Q3 | $19.3M | Sell |
178,008
-244,936
| -58% | -$30.4M | 0.05% | 260 |
|
|
2015
Q2 | $49M | Sell |
422,944
-305,053
| -42% | -$34.9M | 0.14% | 96 |
|
|
2015
Q1 | $83.9M | Sell |
727,997
-75,365
| -9% | -$9.01M | 0.23% | 64 |
|
|
2014
Q4 | $89.9M | Sell |
803,362
-26,959
| -3% | -$2.84M | 0.32% | 57 |
|
|
2014
Q3 | $78.7M | Buy |
830,321
+328,750
| +66% | +$29.7M | 0.07% | 149 |
|
|
2014
Q2 | $43.1M | Sell |
501,571
-389,129
| -44% | -$29.6M | 0.04% | 172 |
|
|
2014
Q1 | $65.5M | Sell |
890,700
-671,610
| -43% | -$53.2M | 0.05% | 146 |
|
|
2013
Q4 | $132M | Buy |
1,562,310
+36,712
| +2% | +$2.9M | 0.1% | 116 |
|
|
2013
Q3 | $118M | Buy |
1,525,598
+885,632
| +138% | +$62.1M | 0.09% | 133 |
|
|
2013
Q2 | $37.4M | Buy |
+639,966
| New | +$38.5M | 0.03% | 182 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
BNP Paribas Financial Markets's CELG Position: Q4 2019 in Review
BNP Paribas Financial Markets sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 572,196 shares — an estimated $56.8M sold.
BNP Paribas Financial Markets first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $194M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- BNP Paribas Financial Markets reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 572,196 Celgene Corp shares in Q4 2019, an estimated $56.8M.
- BNP Paribas Financial Markets first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- BNP Paribas Financial Markets's Celgene Corp position peaked at $194M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.